Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TNFSF9 Antikörper (Extracellular Domain)

TNFSF9 Reaktivität: Human WB, ELISA, FACS, ICC Wirt: Maus Monoclonal 41B436 unconjugated
Produktnummer ABIN1169256
  • Target Alle TNFSF9 Antikörper anzeigen
    TNFSF9 (Tumor Necrosis Factor (Ligand) Superfamily, Member 9 (TNFSF9))
    Bindungsspezifität
    • 15
    • 8
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Extracellular Domain
    Reaktivität
    • 57
    • 30
    • 15
    Human
    Wirt
    • 41
    • 19
    • 10
    • 2
    Maus
    Klonalität
    • 37
    • 32
    • 2
    Monoklonal
    Konjugat
    • 39
    • 6
    • 5
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser TNFSF9 Antikörper ist unkonjugiert
    Applikation
    • 46
    • 36
    • 30
    • 13
    • 13
    • 8
    • 6
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
    Spezifität
    Recognizes extracellular domain of human CD137L.
    Kreuzreaktivität
    Human
    Keine Kreuzreaktivität
    Maus
    Kreuzreaktivität (Details)
    Does not cross-react with mouse CD137L.
    Sterilität
    0.2 μm filtered
    Immunogen
    Recombinant human CD137L extracellular domain.
    Klon
    41B436
    Isotyp
    IgG1
    Top Product
    Discover our top product TNFSF9 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.
    Konservierungsmittel
    Without preservative
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 1 year after receipt when stored at -20°C.
    Haltbarkeit
    12 months
  • Gullo, Koh, Pang, Ho, Tan, Schwarz: "Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling." in: PLoS ONE, Vol. 5, Issue 5, pp. e10845, (2010) (PubMed).

  • Target
    TNFSF9 (Tumor Necrosis Factor (Ligand) Superfamily, Member 9 (TNFSF9))
    Andere Bezeichnung
    CD137L (TNFSF9 Produkte)
    Synonyme
    TNFSF9 antikoerper, 4-1BB-L antikoerper, 4-1BBL antikoerper, AI848817 antikoerper, Cd137l antikoerper, Ly63l antikoerper, CD137L antikoerper, TNF superfamily member 9 antikoerper, tumor necrosis factor (ligand) superfamily, member 9 antikoerper, Tnfsf9 antikoerper, LOC476729 antikoerper, TNFSF9 antikoerper
    Hintergrund
    The CD137 ligand (CD137L, 4-1BBL) is a member of the tumor necrosis factor (TNF) family. CD137L is a type II, transmembrane protein found on activated macrophages, dendritic cells and mature B cells. The interaction with its receptor 4-1BB induces recruitment of TNF receptor-associated factor 1 (TRAF1) and TRAF2 and interaction with the kinase p56lck. CD137 and CD137L have been reported to be involved in tumor rejection, apoptosis, anti-viral immunity, diabetes, in T and B cell co-stimulation and modulation of the immune response.
    UniProt
    P41273
    Pathways
    Activated T Cell Proliferation, Cancer Immune Checkpoints
Sie sind hier:
Kundenservice